Goldman Sachs Group »

Syros Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Syros Pharmaceuticals (SYRS) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Syros Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syros Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syros Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9M 240k 7.79
2023-09-30 $421k 107k 3.95
2023-06-30 $332k 105k 3.15
2023-03-31 $281k 105k 2.67
2022-12-31 $45k 12k 3.59